NSEAnalysts/Institutional Investor Meet/Con. Call Updates3 Aug 2026 · 3 Aug 2026, 08:46 pm
Analysts/Institutional Investor Meet/Con. Call Updates
GlaxoSmithKline Pharmaceuticals Limited · GLAXO
✦ AI Summary
GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange about the link of recording of Analysts/Institutional Investor Meet/Con. Call Updates.
Analysis Scores
Earnings Impact0/10
Growth Catalyst0/10
Governance Concern0/10
Regulatory Risk0/10
Balance Sheet Risk0/10
Liquidity Impact0/10
Market Sentiment0/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange about Link of Recording
Attachments (1)
📄pdf
Download →
GLAXO1924_03082026204644_AnalystMeetOutcome_-_Copy.pdf
View document text
GlaxoSmithKline Pharmaceuticals Limited
GSK House, Dr. Annie Besant Road,
Worli, Mumbai - 400 030
Tel No: +91 22 2495 9595
Fax No: +91 22 2495 9494
Web: www.gsk-india.com
Email: askus@gsk.com
3rd August 2026
BSE LIMITED THE NATIONAL STOCK EXCHANGE OF INDIA LIMITED
Phiroze Jeejeebhoy Towers Exchange Plaza, 5th Floor, Plot No. C/1, G Block
Dalal Street Bandra-Kurla Complex, Bandra (East)
Mumbai - 400001 Mumbai - 400051
Dear Sirs,
Subject: Outcome of Schedule of Analyst / Institutional Investor Meetings
Pursuant to Regulation 30 read with Part A of Schedule Ill of SEBI (Listing Obligations and
Disclosure Requirements) Regulations, 2015, the recording is uploaded at Audio file –
https://india-pharma.gsk.com/en-in/investors/analyst-meets/
Thanking you,
Yours faithfully
For GlaxoSmithKline Pharmaceuticals Limited
Ajay Nadkarni
Vice President – Administration, Real Estate
& Company Secretary
CIN: L24239MH1924PLC001151